See more : Tassal Group Limited (TGR.AX) Income Statement Analysis – Financial Results
Complete financial analysis of Micron Solutions, Inc. (MICRD) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Micron Solutions, Inc., a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
- BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A. (BML.WA) Income Statement Analysis – Financial Results
- Teract S.A. (TRACT.PA) Income Statement Analysis – Financial Results
- Megasoft Limited (MEGASOFT.BO) Income Statement Analysis – Financial Results
- Hangzhou Cable Co., Ltd. (603618.SS) Income Statement Analysis – Financial Results
- Asia Sermkij Leasing Public Company Limited (ASK.BK) Income Statement Analysis – Financial Results
Micron Solutions, Inc. (MICRD)
Industry: Medical - Instruments & Supplies
Sector: Healthcare
Website: https://www.micronsolutionsinc.com
About Micron Solutions, Inc.
Micron Solutions, Inc. operates as a contract manufacturer for the medical device, defense, and life sciences markets. It offers precision machining, thermoplastic injection molding, mold making products; sensors; orthopedic implants and devices; and diagnostic test kits. The company provides solutions for medical, orthopedics, consumer, and automotive industries. Micron Solutions, Inc. was founded in 1978 and is based in Fitchburg, Massachusetts.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|
| Revenue | 22.56M | 20.41M | 20.84M | 17.50M | 19.56M | 20.10M | 19.64M |
| Cost of Revenue | 19.71M | 18.56M | 17.29M | 15.74M | 17.24M | 17.81M | 16.74M |
| Gross Profit | 2.85M | 1.85M | 3.55M | 1.76M | 2.32M | 2.29M | 2.90M |
| Gross Profit Ratio | 12.63% | 9.07% | 17.02% | 10.07% | 11.88% | 11.40% | 14.76% |
| Research & Development | 0.00 | 0.00 | 0.00 | 80.36K | 106.81K | 111.01K | 97.23K |
| General & Administrative | 3.31M | 2.88M | 2.80M | 2.76M | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 717.62K | 457.21K | 528.79K | 636.17K | 0.00 | 0.00 | 0.00 |
| SG&A | 4.03M | 3.34M | 3.33M | 3.27M | 2.97M | 3.20M | 3.30M |
| Other Expenses | 1.00 | 500.00 | 43.21K | 5.83K | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 4.03M | 3.34M | 3.33M | 3.35M | 3.08M | 3.31M | 3.40M |
| Cost & Expenses | 23.74M | 21.90M | 20.62M | 19.08M | 20.32M | 21.12M | 20.14M |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 129.93K | 128.95K | 322.67K | 431.54K | 391.44K | 395.09K | 259.76K |
| Depreciation & Amortization | 853.44K | 1.11M | 1.30M | 1.46M | 1.50M | 1.61M | 1.54M |
| EBITDA | -308.40K | 2.96M | 2.77M | -246.15K | 799.34K | 650.17K | 1.09M |
| EBITDA Ratio | -1.37% | -1.85% | 7.25% | -0.70% | 3.82% | 2.95% | 5.29% |
| Operating Income | -1.18M | -1.49M | 214.22K | -1.59M | -757.58K | -1.02M | -502.83K |
| Operating Income Ratio | -5.23% | -7.28% | 1.03% | -9.06% | -3.87% | -5.07% | -2.56% |
| Total Other Income/Expenses | -111.93K | 3.21M | 933.66K | -555.71K | -338.56K | -337.67K | -209.63K |
| Income Before Tax | -1.29M | 1.73M | 1.15M | -2.14M | -1.10M | -1.36M | -712.46K |
| Income Before Tax Ratio | -5.72% | 8.46% | 5.51% | -12.24% | -5.60% | -6.75% | -3.63% |
| Income Tax Expense | 1.37K | -4.00 | 1.00 | -3.00 | 2.17K | -960.00 | 4.00 |
| Net Income | -1.29M | 1.73M | 1.15M | -2.14M | -1.10M | -1.36M | -712.46K |
| Net Income Ratio | -5.73% | 8.46% | 5.51% | -12.24% | -5.61% | -6.74% | -3.63% |
| EPS | -0.41 | 0.57 | 0.39 | -0.74 | -0.39 | -0.48 | -0.25 |
| EPS Diluted | -0.41 | 0.54 | 0.39 | -0.74 | -0.39 | -0.48 | -0.25 |
| Weighted Avg Shares Out | 3.15M | 3.05M | 2.93M | 2.88M | 2.85M | 2.82M | 2.82M |
| Weighted Avg Shares Out (Dil) | 3.15M | 3.23M | 2.95M | 2.88M | 2.85M | 2.82M | 2.82M |
Source: https://incomestatements.info
Category: Stock Reports